Table 3 Summary statistics of primary endpoint (the difference in the 1/SCr versus time slope between run-in period [R0 ~ R20] and treatment period [W4 ~ W28])
Treatment group | No. of patients | 1/SCr versus time slope (dL/mg over 4 weeks) | Difference in the 1/SCr versus time slope (dL/mg over 4 weeks) | ||||
|---|---|---|---|---|---|---|---|
|  |  | Run-in period (R0 ~ R20) | Treatment period (W4 ~ W28) |  |  | ||
| Â | Â | Mean | SD | Mean | SD | Mean | SD |
Placebo | 34 | −0.0121 | 0.00497 | −0.0074 | 0.00935 | 0.0047 | 0.01087 |
120 μg | 32 | −0.0154 | 0.00808 | −0.0040 | 0.01345 | 0.0113 | 0.01011 |
240 μg | 36 | −0.0120 | 0.00788 | −0.0045 | 0.00750 | 0.0075 | 0.00953 |